Scientists at Lazzaro Spallanzani National Institute for Infectious Diseases in Italy have claimed that a vaccine candidate could neutralise coronavirus within human cells.
According to findings from the tests conducted at Spallanzani Hospital in Rome, the vaccine generated antibodies in mice that work on human cells.
These antibodies were observed to prevent the virus from infecting the cells. Takis Biotech is the company developing the coronavirus vaccine candidate.
An Italian news agency, ANSA, quoted Takis Biotech CEO Luigi Aurisicchio as saying: “This is the most advanced stage of testing of a candidate vaccine created in Italy.